DWC Posts Revised MTUS Drug List Effective February 15, 2024
The Division of Workers’ Compensation (DWC) Administrative Director George Parisotto issued an order updating the Medical Treatment Utilization Schedule (MTUS) Drug List, effective February 15, 2024, to adopt changes based on updated American College of Occupational and Environmental Medicine (ACOEM) Shoulder Guideline and COVID-19 Guideline. DWC has now posted a revised MTUS Drug List v.11.1 to correct two technical errors in the listing of brand name examples. The corrected brand name examples include the following.
- “diclofenac epolamine” brand example is identified as Flector
- “fluvastatin sodium er” brand example is identified as “Lescol XL”
The updated MTUS Drug List v.11.1 and the Administrative Director Order can be accessed on the DWC MTUS drug formulary webpage.
DWC welcomes comments from the public on the formulary drug list. Injured workers, physicians, pharmacists, and others may submit their questions, comments, and suggestions to the DWC. All correspondence should be directed to Formulary@dir.ca.gov.
- Recent News:
- News Releases
- DWC Newslines
- Subscribe:
